Serofendic acid protects against myocardial ischemia-reperfusion injury in rats

Journal of Pharmacological Sciences

Volumn 126, Issue 3, 2014, Pages 274-280

  Ioroi, Tadaaki ^a   Akao, Masaharu ^b,c   Iguchi, Moritake ^b,c   Kato, Masashi ^b   Kimura, Takeshi ^b   Izumi, Yasuhiko ^a   Akaike, Akinori ^a,d   Kume, Toshiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Cardiac myocyte; Mitochondrial atp sensitive potassium channel; Myocardial ischemia; Reperfusion; Serofendic acid

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CARDIAC AGENT; GLUCOSE; SEROFENDIC ACID; UNCLASSIFIED DRUG; DITERPENE; MITOCHONDRIAL K(ATP) CHANNEL; POTASSIUM CHANNEL; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; RAT; REPERFUSION INJURY; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; HEART MITOCHONDRION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BLOOD PRESSURE; CYTOPROTECTION; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; POTASSIUM CHANNELS; PROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84919785137     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.14139FP     Document Type: Article

References (38)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135.
2. Inserte J, Barrabés JA, Hernando V, Garcia-Dorado D. Orphan targets for reperfusion injury. Cardiovasc Res. 2009;83:169-178.
3. Prasad A, Stone GW, Holmes DR, Gersh B. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion. Circulation. 2009;120:2105-2112.
4. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998;60:619-642.
5. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res. 2003;93:292-301.
6. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305:626-629.
7. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341:233-249.
8. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res. 2004;95:957-970.
9. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 2004;61:372-385.
10. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004;287:C817-C833.
11. Akao M, Ohler A, O'Rourke B, Marbán E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res. 2001;88:1267-1275.
12. Akao M, Teshima Y, Marbán E. Antiapoptotic effect of nicorandil mediated by mitochondrial ATP-sensitive potassium channels in cultured cardiac myocytes. J Am Coll Cardiol. 2002;40:803-810.
13. Teshima Y, Akao M, Li RA, Chong TH, Baumgartner WA, Johnston MV, et al. Mitochondrial ATP-sensitive potassium channel activation protects cerebellar granule neurons from apoptosis induced by oxidative stress. Stroke. 2003;34:1796-1802.
14. Teshima Y, Akao M, Baumgartner WA, Marbán E. Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels. Brain Res. 2003;990:45-50.
15. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res. 2001;89:891-898.
16. Akao M, O'Rourke B, Kusuoka H, Teshima Y, Jones SP, Marbán E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ Res. 2003;92:195-202.
17. Akao M, O'Rourke B, Teshima Y, Seharaseyon J, Marbán E. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ Res. 2003;92:186-194.
18. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res. 1997;81:1072-1082.
19. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardio-protection? Circulation. 1998;97:2463-2469.
20. Fryer RM, Eells JT, Hsu AK, Henry MM, Gross GJ. Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol. 2000;278:H305-H312.
21. Miura T, Liu Y, Kita H, Ogawa T, Shimamoto K. Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol. 2000;35:238-245.
22. Kume T, Asai N, Nishikawa H, Mano N, Terauchi T, Taguchi R, et al. Isolation of a diterpenoid substance with potent neuroprotective activity from fetal calf serum. Proc Natl Acad Sci U S A. 2002;99:3288-3293.
23. Taguchi R, Nishikawa H, Kume T, Terauchi T, Kaneko S, Katsuki H, et al. Serofendic acid prevents acute glutamate neurotoxicity in cultured cortical neurons. Eur J Pharmacol. 2003;477:195-203.
24. Osakada F, Kawato Y, Kume T, Katsuki H, Sugimoto H, Akaike A. Serofendic acid, a sulfur-containing diterpenoid derived from fetal calf serum, attenuates reactive oxygen species-induced oxidative stress in cultured striatal neurons. J Pharmacol Exp Ther. 2004;311:51-59.
25. Kume T, Kawai Y, Yoshida K, Nakamizo T, Kanki R, Sawada H, et al. Protective effect of serofendic acid on glutamate-induced neurotoxicity in rat cultured motor neurons. Neurosci Lett. 2005;383:199-202.
26. Kume T, Taguchi R, Katsuki H, Akao M, Sugimoto H, Kaneko S, et al. Serofendic acid, a neuroprotective substance derived from fetal calf serum, inhibits mitochondrial membrane depolarization and caspase-3 activation. Eur J Pharmacol. 2006;542:69-76.
27. Takeda T, Akao M, Matsumoto-Ida M, Kato M, Takenaka H, Kihara Y, et al. Serofendic acid, a novel substance extracted from fetal calf serum, protects against oxidative stress in neonatal rat cardiac myocytes. J Am Coll Cardiol. 2006;47:1882-1890.
28. Akao M, Takeda T, Kita T, Kume T, Akaike A. Serofendic acid, a substance extracted from fetal calf serum, as a novel drug for cardioprotection. Cardiovasc Drug Rev. 2007;25:333-341.
29. Tanno M, Tsuchida A, Nozawa Y, Matsumoto T, Hasegawa T, Miura T, et al. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat. J Cardiovasc Pharmacol. 2000;35:345-352.
30. Matsumoto-Ida M, Akao M, Takeda T, Kato M, Kita T. Real-time 2-photon imaging of mitochondrial function in perfused rat hearts subjected to ischemia/reperfusion. Circulation. 2006;114:1497-1503.
31. Pratz J, Mondot S, Montier F, Cavero I. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. J Pharmacol Exp Ther. 1991;258:216-222.
32. Mariot P, Gilon P, Nenquin M, Henquin JC. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells. Diabetes. 1998;47:365-373.
33. Wang Y, Haider HK, Ahmad N, Ashraf M. Mechanisms by which K(ATP) channel openers produce acute and delayed cardioprotection. Vascul Pharmacol. 2005;42:253-264.
34. Gross GJ. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol. 1995;90:85-88.
35. O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res. 2000;87:845-855.
36. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003;60: 617-625.
37. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res. 2004;94:7-16.
38. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res. 2004;94:420-432.